EU ingredient rules · 1 min read
Triclocarban in cosmetics: EU rules
Quick answer: Triclocarban is a restricted cosmetic ingredient in the EU: Annex III (entry 100) allows it only within set limits, at up to 1.5% in the ready-to-use product. It also appears under Annex V. CosIng lists its functions as antimicrobial, deodorant and preservative.
Key facts
| INCI name | TRICLOCARBAN |
|---|---|
| CAS number | 101-20-2 |
| EC number | 202-924-1 |
| EU status | Restricted (Annex III, entry 100); Permitted preservative (Annex V, entry 23) |
| Functions (CosIng) | Antimicrobial, Deodorant, Preservative |
What it does in a product
- Antimicrobial: Helps limit the growth of microorganisms on the skin or in the mouth.
- Deodorant: Reduces or masks body odor.
- Preservative: Protects the product itself from bacteria and mold, which is a big part of why an opened product stays usable.
Annex III: restricted substances, entry 100
Annex III lists substances that cosmetics may contain only within the limits set there, such as a maximum concentration, the product types they may be used in, and warnings that must appear on the label.
The entry is listed as 1-(4-Chlorophenyl)-3-(3,4-dichlorophenyl)urea (13)
Maximum concentration in the ready-to-use product: 1.5%
Product type or body part:
Rinse-off products
Other conditions:
Purity criteria: 3, 3', 4, 4'-Tetrachloroazobenzene<=1ppm; 3, 3', 4, 4'-Tetrachloroazoxybenzene<=1ppm. For purposes other than inhibiting the development of micro-organisms in the product. This purpose has to be apparent from the presentation of the product
III (13) For use as a preservative, see Annex V, No. 23
Most recent legal act listed by CosIng for this entry: Regulation (EC) 2009/1223.
Scientific Committee on Consumer Safety (SCCS) opinions:
Annex V: permitted preservatives, entry 23
Annex V is the list of preservatives allowed in cosmetic products in the EU, each with a maximum concentration. A substance used mainly to stop microorganisms growing in a product must be on this list.
The entry is listed as 1-(4-Chlorophenyl)-3-(3,4-dichlorophenyl)urea
Maximum concentration in the ready-to-use product: 0.2%
Product type or body part:
All cosmetic products, with the exception of mouthwash.
Other conditions:
Purity criteria: 3,3',4,4'-Tetrachloroazobenzene ≤ 1 ppm 3,3',4,4'-Tetrachloroazoxybenzene ≤ 1 ppm
Not to be used in toothpaste intended for children under 6 years of age.
Cosmetic products containing that substance that do not comply with the conditions may, provided that they comply with the conditions applicable on 23 April 2024, be placed on the Union market until 31 December 2024 and, if they have already been placed on the market before that date, continue to be made available on the Union market until 31 October 2025.
Conditions of use and warnings:
For toothpaste containing Triclocarban the following labelling is obligatory: ‘Not to be used for children under 6 years of age’.
V (6) For use other than as a preservative, see Annex III, No. 100
Most recent legal act listed by CosIng for this entry: Regulation (EU) 2024/996.
Scientific Committee on Consumer Safety (SCCS) opinions:
- Opinion concerning Restrictions on Materials listed in annex VI of Directive 76/768/EEC on Cosmetic Products
- Opinion on Triclocarban - For other uses than as a preservative
- Request for a scientific advice on the safety of triclocarban and triclosan as substances with potential endocrine disrupting properties
Why it matters for shelf life
Preservatives are a large part of why an opened product stays safe to use until the end of its period after opening (the open-jar symbol). Once that period has passed, or if water, fingers or heat have got into the product, the preservative system may no longer keep microbes in check.
Not sure how to read a label? What an INCI name is · How ingredient lists work
Source
European Commission, CosIng (Cosmetic Ingredients database), entries for TRICLOCARBAN and Annex III/100 and Annex V/23, retrieved 2026-10-11. CosIng is provided for information only and has no legal value; the legally binding text is Regulation (EC) No 1223/2009 and its amendments as published in the Official Journal of the European Union. Rules outside the EU, for example in the US, can differ. This page is not legal or medical advice.